We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Draft Guidance on HPV IVD Trials Needs More Clarity, Industry Says
Draft Guidance on HPV IVD Trials Needs More Clarity, Industry Says
January 6, 2010
Diagnostics companies want more clarity and fewer sample requirements in the FDA’s final guidance on clinical studies of in vitro diagnostics (IVDs) for human papillomavirus (HPV).